A new trading day began on Monday, with Chimerix Inc (NASDAQ: CMRX) stock price down -3.55% from the previous day of trading, before settling in for the closing price of $3.94. CMRX’s price has ranged from $0.75 to $4.22 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 347.46%. Meanwhile, its annual earnings per share averaged -6.55%. With a float of $79.66 million, this company’s outstanding shares have now reached $89.94 million.
Let’s determine the extent of company efficiency that accounts for 72 employees. In terms of profitability, gross margin is -13286.16%, operating margin of -58380.5%, and the pretax margin is -52574.84%.
Chimerix Inc (CMRX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Chimerix Inc is 11.42%, while institutional ownership is 41.80%. The most recent insider transaction that took place on Jan 30 ’25, was worth 11,470. In this transaction VP OF FINANCE AND ACCOUNTING of this company sold 2,800 shares at a rate of $4.10, taking the stock ownership to the 149,287 shares. Before that another transaction happened on Jan 30 ’25, when Company’s CHIEF FINANCIAL OFFICER sold 1,015 for $4.11, making the entire transaction worth $4,172. This insider now owns 175,237 shares in total.
Chimerix Inc (CMRX) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.29 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -6.55% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.11% during the next five years compared to 8.31% growth over the previous five years of trading.
Chimerix Inc (NASDAQ: CMRX) Trading Performance Indicators
Here are Chimerix Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.33. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2136.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.94, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -1.04 in one year’s time.
Technical Analysis of Chimerix Inc (CMRX)
Looking closely at Chimerix Inc (NASDAQ: CMRX), its last 5-days average volume was 1.23 million, which is a drop from its year-to-date volume of 1.43 million. As of the previous 9 days, the stock’s Stochastic %D was 56.62%. Additionally, its Average True Range was 0.28.
During the past 100 days, Chimerix Inc’s (CMRX) raw stochastic average was set at 87.72%, which indicates a significant increase from 56.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.32% in the past 14 days, which was lower than the 191.14% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.72, while its 200-day Moving Average is $1.36. However, in the short run, Chimerix Inc’s stock first resistance to watch stands at $3.93. Second resistance stands at $4.07. The third major resistance level sits at $4.14. If the price goes on to break the first support level at $3.72, it is likely to go to the next support level at $3.65. Now, if the price goes above the second support level, the third support stands at $3.51.
Chimerix Inc (NASDAQ: CMRX) Key Stats
With a market capitalization of 341.76 million, the company has a total of 89,936K Shares Outstanding. Currently, annual sales are 320 K while annual income is -82,100 K. The company’s previous quarter sales were 30 K while its latest quarter income was -22,880 K.
